Published in Diabetes Care on April 01, 2003
A bihormonal closed-loop artificial pancreas for type 1 diabetes. Sci Transl Med (2010) 5.67
The barrier of hypoglycemia in diabetes. Diabetes (2008) 4.50
Outpatient glycemic control with a bionic pancreas in type 1 diabetes. N Engl J Med (2014) 3.38
Hypoglycaemia in Type 2 diabetes. Diabet Med (2008) 3.00
Blood glucose control in type 1 diabetes with a bihormonal bionic endocrine pancreas. Diabetes Care (2012) 2.90
Frequency of hypoglycemia and its significance in chronic kidney disease. Clin J Am Soc Nephrol (2009) 2.01
Frequent hypoglycemia among elderly patients with poor glycemic control. Arch Intern Med (2011) 1.93
Can a tool that automates insulin titration be a key to diabetes management? Diabetes Technol Ther (2012) 1.63
Day and night glycaemic control with a bionic pancreas versus conventional insulin pump therapy in preadolescent children with type 1 diabetes: a randomised crossover trial. Lancet Diabetes Endocrinol (2016) 1.59
Biomarkers related to severe hypoglycaemia and lack of good glycaemic control in ACCORD. Diabetologia (2015) 1.41
Second-line therapy in patients with type 2 diabetes inadequately controlled with metformin monotherapy: a systematic review and mixed-treatment comparison meta-analysis. Open Med (2011) 1.41
Autonomous and continuous adaptation of a bihormonal bionic pancreas in adults and adolescents with type 1 diabetes. J Clin Endocrinol Metab (2014) 1.29
HbA1c and risk of severe hypoglycemia in type 2 diabetes: the Diabetes and Aging Study. Diabetes Care (2013) 1.27
Counterpoint: Intensive glucose control and mortality in ACCORD--still looking for clues. Diabetes Care (2010) 1.20
Place of sulfonylureas in the management of type 2 diabetes mellitus in South Asia: A consensus statement. Indian J Endocrinol Metab (2015) 1.18
Increasing trend in the number of severe hypoglycemia patients in Korea. Diabetes Metab J (2011) 1.16
Minimizing the risk of hypoglycemia with vildagliptin: Clinical experience, mechanistic basis, and importance in type 2 diabetes management. Diabetes Ther (2011) 1.13
Hypoglycemia in type 1 diabetes. Diabetes (2010) 1.13
Avoiding hypoglycemia: a key to success for glucose-lowering therapy in type 2 diabetes. Vasc Health Risk Manag (2013) 1.09
Uncovering undetected hypoglycemic events. Diabetes Metab Syndr Obes (2012) 1.07
Cost-effectiveness of second-line antihyperglycemic therapy in patients with type 2 diabetes mellitus inadequately controlled on metformin. CMAJ (2011) 1.05
Severe hypoglycemia symptoms, antecedent behaviors, immediate consequences and association with glycemia medication usage: Secondary analysis of the ACCORD clinical trial data. BMC Endocr Disord (2012) 1.03
Gastric electrical stimulation with the TANTALUS System in obese type 2 diabetes patients: effect on weight and glycemic control. J Diabetes Sci Technol (2009) 1.02
Substantial reductions in the number of diabetic ketoacidosis and severe hypoglycaemia episodes requiring emergency treatment lead to reduced costs after structured education in adults with Type 1 diabetes. Diabet Med (2014) 1.02
Hypoglycemia: The neglected complication. Indian J Endocrinol Metab (2013) 1.01
Effects of intensive glucose lowering in the management of patients with type 2 diabetes mellitus in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. Circulation (2010) 1.00
Insulin patch pumps: their development and future in closed-loop systems. Diabetes Technol Ther (2010) 1.00
Substantial increase in incidence of severe hypoglycemia between 1997-2000 and 2007-2010: a German longitudinal population-based study. Diabetes Care (2012) 0.96
Severe hypoglycaemia in drug-treated diabetic patients needs attention: a population-based study. Scand J Prim Health Care (2011) 0.94
Efficacy of vildagliptin in combination with insulin in patients with type 2 diabetes and severe renal impairment. Vasc Health Risk Manag (2013) 0.94
Cost-effectiveness of MODY genetic testing: translating genomic advances into practical health applications. Diabetes Care (2013) 0.94
Fear of hypoglycaemia: defining a minimum clinically important difference in patients with type 2 diabetes. Health Qual Life Outcomes (2009) 0.94
Prevalence and Incidence of Hypoglycaemia in 532,542 People with Type 2 Diabetes on Oral Therapies and Insulin: A Systematic Review and Meta-Analysis of Population Based Studies. PLoS One (2015) 0.93
Patient-level meta-analysis of the EDITION 1, 2 and 3 studies: glycaemic control and hypoglycaemia with new insulin glargine 300 U/ml versus glargine 100 U/ml in people with type 2 diabetes. Diabetes Obes Metab (2015) 0.92
Diabetes Mellitus, Obesity, and Diagnosis of Amyotrophic Lateral Sclerosis: A Population-Based Study. JAMA Neurol (2015) 0.91
Presence of macroalbuminuria predicts severe hypoglycemia in patients with type 2 diabetes: a 10-year follow-up study. Diabetes Care (2012) 0.89
Progress of artificial pancreas devices towards clinical use: the first outpatient studies. Curr Opin Endocrinol Diabetes Obes (2015) 0.88
Evaluation of the cost effectiveness of exenatide versus insulin glargine in patients with sub-optimally controlled type 2 diabetes in the United Kingdom. Cardiovasc Diabetol (2008) 0.88
Treatment of severe diabetic hypoglycemia with glucagon: an underutilized therapeutic approach. Diabetes Metab Syndr Obes (2011) 0.88
Avoiding or coping with severe hypoglycemia in patients with type 2 diabetes. Korean J Intern Med (2014) 0.88
Do clinical standards for diabetes care address excess risk for hypoglycemia in vulnerable patients? A systematic review. Health Serv Res (2013) 0.87
Causative anti-diabetic drugs and the underlying clinical factors for hypoglycemia in patients with diabetes. World J Diabetes (2015) 0.87
Severe hypoglycaemia in adults with insulin-treated diabetes: impact on healthcare resources. Diabet Med (2015) 0.85
Impact of clinical factors and CYP2C9 variants for the risk of severe sulfonylurea-induced hypoglycemia. Eur J Clin Pharmacol (2011) 0.85
Approach to assessing the economic impact of insulin-related hypoglycaemia using the novel Local Impact of Hypoglycaemia Tool. Diabet Med (2015) 0.85
Minimizing morbidity of hypoglycemia in diabetes: a review of mini-dose glucagon. J Diabetes Sci Technol (2014) 0.84
Efficacy and safety of fasiglifam (TAK-875), a G protein-coupled receptor 40 agonist, in Japanese patients with type 2 diabetes inadequately controlled by diet and exercise: a randomized, double-blind, placebo-controlled, phase III trial. Diabetes Obes Metab (2015) 0.83
Healthcare resource implications of hypoglycemia-related hospital admissions and inpatient hypoglycemia: retrospective record-linked cohort studies in England. BMJ Open Diabetes Res Care (2015) 0.83
Diabetic emergencies - ketoacidosis, hyperglycaemic hyperosmolar state and hypoglycaemia. Nat Rev Endocrinol (2016) 0.83
Hypoglycemia in Patients with Diabetes and Renal Disease. J Clin Med (2015) 0.83
An observational study of patient characteristics and mortality following hypoglycemia in the community. BMJ Open Diabetes Res Care (2015) 0.82
Insulin degludec/insulin aspart combination for the treatment of type 1 and type 2 diabetes. Vasc Health Risk Manag (2014) 0.82
Low socioeconomic status is associated with increased risk for hypoglycemia in diabetes patients: the Diabetes Study of Northern California (DISTANCE). J Health Care Poor Underserved (2014) 0.82
Risk factors for 30-day readmission following hypoglycemia-related emergency room and inpatient admissions. BMJ Open Diabetes Res Care (2016) 0.81
A novel algorithm for prediction and detection of hypoglycemia based on continuous glucose monitoring and heart rate variability in patients with type 1 diabetes. J Diabetes Sci Technol (2014) 0.81
Higher accuracy of self-monitoring of blood glucose in insulin-treated patients in Germany: clinical and economical aspects. J Diabetes Sci Technol (2013) 0.81
Combining information of autonomic modulation and CGM measurements enables prediction and improves detection of spontaneous hypoglycemic events. J Diabetes Sci Technol (2014) 0.81
Toward Big Data Analytics: Review of Predictive Models in Management of Diabetes and Its Complications. J Diabetes Sci Technol (2015) 0.81
Incidence and care-related costs of severe hypoglycaemia requiring emergency treatment in Andalusia (Spain): the PAUEPAD project. Diabet Med (2015) 0.81
Comment on: Holstein et al. Substantial increase in incidence of severe hypoglycemia between 1997-2000 and 2007-2010: a german longitudinal population-based study. Diabetes Care 2012;35:972-975. Diabetes Care (2012) 0.80
Antecedent hindbrain glucoprivation does not impair the counterregulatory response to hypoglycemia. Diabetes (2007) 0.80
Insulin initiation and intensification in patients with T2DM for the primary care physician. Diabetes Metab Syndr Obes (2011) 0.80
Health economic evaluation of type 2 diabetes mellitus: a clinical practice focused review. Clin Med Insights Endocrinol Diabetes (2015) 0.79
Emergency management of diabetes and hypoglycaemia. Emerg Med J (2006) 0.79
Reduced risk of hypoglycemia with once-daily glargine versus twice-daily NPH and number needed to harm with NPH to demonstrate the risk of one additional hypoglycemic event in type 2 diabetes: Evidence from a long-term controlled trial. J Diabetes Complications (2014) 0.79
Home use of a bihormonal bionic pancreas versus insulin pump therapy in adults with type 1 diabetes: a multicentre randomised crossover trial. Lancet (2016) 0.78
Population-based study of severe hypoglycemia requiring emergency medical service assistance reveals unique findings. J Diabetes Sci Technol (2012) 0.78
Cellular immunoisolation for islet transplantation by a novel dual porosity electrospun membrane. Transplant Proc (2011) 0.78
Evaluation of a diabetes referral pathway for the management of hypoglycaemia following emergency contact with the ambulance service to a diabetes specialist nurse team. Emerg Med J (2006) 0.78
Development of a Microsphere-Based System to Facilitate Real-Time Insulin Monitoring. J Diabetes Sci Technol (2016) 0.77
Severe hypoglycemia in patients with diabetes. Diabetes Metab J (2012) 0.77
A pilot study to compare meal-triggered gastric electrical stimulation and insulin treatment in Chinese obese type 2 diabetes. Diabetes Technol Ther (2015) 0.77
An estimation of the long-term clinical and economic benefits of insulin lispro in Type 1 diabetes in the UK. Diabet Med (2009) 0.77
Mechanisms of hypoglycemia unawareness and implications in diabetic patients. World J Diabetes (2015) 0.76
Attenuated sympathoadrenal responses, but not severe hypoglycemia, during aggressive glycemic therapy of early type 2 diabetes. Diabetes (2009) 0.76
Severe hypoglycemia in the Look AHEAD Trial. J Diabetes Complications (2016) 0.76
Trends in Emergency Department Visit Rates for Hypoglycemia and Hyperglycemic Crisis among Adults with Diabetes, United States, 2006-2011. PLoS One (2015) 0.75
Hypoglycemia in Diabetes Mellitus as a Coronary Artery Disease Risk Factor in Patients at Elevated Vascular Risk. J Clin Endocrinol Metab (2015) 0.75
Risk factors of severe hypoglycemia requiring medical assistance and neurological sequelae in patients with diabetes: A case-control study. Medicine (Baltimore) (2016) 0.75
Self-monitoring of blood glucose: one STeP forward? J Diabetes Sci Technol (2012) 0.75
Use of Healthcare Services Following Severe Hypoglycemia in Patients with Diabetes: Analysis of Real-World Data. Diabetes Ther (2016) 0.75
The Potential Cost Implications of Averting Severe Hypoglycemic Events Requiring Hospitalization in High-Risk Adults With Type 1 Diabetes Using Real-Time Continuous Glucose Monitoring. J Diabetes Sci Technol (2016) 0.75
Improving self-referral for diabetes care following hypoglycaemic emergencies: a feasibility study with linked patient data analysis. BMC Emerg Med (2016) 0.75
Hazardous factors besides infection in hypoglycemia. Biomed Rep (2017) 0.75
A retrospective study on epidemiology of hypoglycemia in Emergency Department. Indian J Endocrinol Metab (2017) 0.75
Incidence of severe hypoglycaemic episodes in patients with type 2 diabetes in the Basque country: impact on healthcare costs. BMC Health Serv Res (2015) 0.75
Event and Cost Offsets of Switching 20% of the Type 1 Diabetes Population in Germany From Multiple Daily Injections to Continuous Subcutaneous Insulin Infusion: A 4-Year Simulation Model. J Diabetes Sci Technol (2016) 0.75
Letter: Cardiovascular Disease Predicts Severe Hypoglycemia in Patients with Type 2 Diabetes (Diabetes Metab J 2015;39:498-506). Diabetes Metab J (2016) 0.75
Abnormal Nocturnal Behavior due to Hypoglycemia in a Patient with Type 2 Diabetes. J Clin Sleep Med (2016) 0.75
Biphasic insulin Aspart 30 vs. NPH plus regular human insulin in type 2 diabetes patients; a cost-effectiveness study. BMC Endocr Disord (2016) 0.75
The cost of Type 1 diabetes mellitus in the United Kingdom: a review of cost-of-illness studies. Eur J Health Econ (2012) 0.75
Type 1 Diabetes - A Clinical Perspective. Point Care (2017) 0.75
A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science (2007) 37.88
Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes. Nat Genet (2008) 35.06
Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes. Science (2007) 32.97
New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet (2010) 17.89
Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat Genet (2010) 16.96
Genome-wide association analysis identifies 20 loci that influence adult height. Nat Genet (2008) 16.92
Common variants near MC4R are associated with fat mass, weight and risk of obesity. Nat Genet (2008) 15.94
Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med (2003) 13.99
Metformin and reduced risk of cancer in diabetic patients. BMJ (2005) 13.04
Two variants on chromosome 17 confer prostate cancer risk, and the one in TCF2 protects against type 2 diabetes. Nat Genet (2007) 12.65
Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. Nat Genet (2012) 11.09
Variants in MTNR1B influence fasting glucose levels. Nat Genet (2008) 10.85
Large-scale association analysis identifies new risk loci for coronary artery disease. Nat Genet (2012) 7.59
A common variant of HMGA2 is associated with adult and childhood height in the general population. Nat Genet (2007) 6.87
Genetic variation in GIPR influences the glucose and insulin responses to an oral glucose challenge. Nat Genet (2010) 6.66
New users of metformin are at low risk of incident cancer: a cohort study among people with type 2 diabetes. Diabetes Care (2009) 6.17
SLC2A9 is a newly identified urate transporter influencing serum urate concentration, urate excretion and gout. Nat Genet (2008) 5.93
Genome-wide association scan meta-analysis identifies three Loci influencing adiposity and fat distribution. PLoS Genet (2009) 5.81
Large-scale association analyses identify new loci influencing glycemic traits and provide insight into the underlying biological pathways. Nat Genet (2012) 4.73
Assessing the combined impact of 18 common genetic variants of modest effect sizes on type 2 diabetes risk. Diabetes (2008) 4.57
Common variants near ATM are associated with glycemic response to metformin in type 2 diabetes. Nat Genet (2010) 4.42
Genome-wide trans-ancestry meta-analysis provides insight into the genetic architecture of type 2 diabetes susceptibility. Nat Genet (2014) 4.13
Genome-wide association study identifies five loci associated with lung function. Nat Genet (2009) 4.10
Coding Variation in ANGPTL4, LPL, and SVEP1 and the Risk of Coronary Disease. N Engl J Med (2016) 3.88
Common variation in the FTO gene alters diabetes-related metabolic traits to the extent expected given its effect on BMI. Diabetes (2008) 3.76
Common variants in WFS1 confer risk of type 2 diabetes. Nat Genet (2007) 3.58
Genome-wide meta-analysis identifies 11 new loci for anthropometric traits and provides insights into genetic architecture. Nat Genet (2013) 3.25
Novel loci for adiponectin levels and their influence on type 2 diabetes and metabolic traits: a multi-ethnic meta-analysis of 45,891 individuals. PLoS Genet (2012) 3.21
Long-term results of RTOG 91-11: a comparison of three nonsurgical treatment strategies to preserve the larynx in patients with locally advanced larynx cancer. J Clin Oncol (2012) 3.18
Genome-wide association and large-scale follow up identifies 16 new loci influencing lung function. Nat Genet (2011) 3.03
Common variants associated with plasma triglycerides and risk for coronary artery disease. Nat Genet (2013) 2.92
Hypoglycemia in type 2 diabetes: pathophysiology, frequency, and effects of different treatment modalities. Diabetes Care (2005) 2.91
Frequency and predictors of hypoglycaemia in Type 1 and insulin-treated Type 2 diabetes: a population-based study. Diabet Med (2005) 2.78
Guidelines of the Pituitary Society for the diagnosis and management of prolactinomas. Clin Endocrinol (Oxf) (2006) 2.56
Stratifying type 2 diabetes cases by BMI identifies genetic risk variants in LAMA1 and enrichment for risk variants in lean compared to obese cases. PLoS Genet (2012) 2.34
Diabetes and cognitive dysfunction. Lancet (2012) 2.32
Vascular disease and diabetes: is hypoglycaemia an aggravating factor? Diabetes Metab Res Rev (2008) 2.28
Enteropathies in the developing world: neglected effects on global health. Am J Trop Med Hyg (2012) 2.27
Generation Scotland: the Scottish Family Health Study; a new resource for researching genes and heritability. BMC Med Genet (2006) 2.25
Case management of HIV-infected severely malnourished children: challenges in the area of highest prevalence. Lancet (2008) 2.08
The relationship between active travel to school and health-related fitness in children and adolescents: a systematic review. Int J Behav Nutr Phys Act (2011) 2.03
Variation in TCF7L2 influences therapeutic response to sulfonylureas: a GoDARTs study. Diabetes (2007) 2.03
Testing bioequivalence for multiple formulations with power and sample size calculations. Pharm Stat (2012) 2.03
The relationship between type 2 diabetes and cognitive dysfunction: longitudinal studies and their methodological limitations. Eur J Pharmacol (2004) 2.02
Cognitive ability and brain structure in type 1 diabetes: relation to microangiopathy and preceding severe hypoglycemia. Diabetes (2003) 1.97
Effect of nitazoxanide on morbidity and mortality in Zambian children with cryptosporidiosis: a randomised controlled trial. Lancet (2002) 1.92
Screening for and treating left-ventricular abnormalities in diabetes mellitus: a new way of reducing cardiac deaths. Lancet (2002) 1.89
Injury of the posterior ligamentous complex of the thoracolumbar spine: a prospective evaluation of the diagnostic accuracy of magnetic resonance imaging. Spine (Phila Pa 1976) (2009) 1.86
Simplified severe sepsis protocol: a randomized controlled trial of modified early goal-directed therapy in Zambia. Crit Care Med (2014) 1.84
Child health in armed conflict: time to rethink. Lancet (2006) 1.82
An evaluation of methods of assessing impaired awareness of hypoglycemia in type 1 diabetes. Diabetes Care (2007) 1.77
Outcome of salvage total laryngectomy following organ preservation therapy: the Radiation Therapy Oncology Group trial 91-11. Arch Otolaryngol Head Neck Surg (2003) 1.76
Influence of an early-onset age of type 1 diabetes on cerebral structure and cognitive function. Diabetes Care (2005) 1.72
A genome-wide association search for type 2 diabetes genes in African Americans. PLoS One (2012) 1.72
Acute hyperglycemia alters mood state and impairs cognitive performance in people with type 2 diabetes. Diabetes Care (2004) 1.71
Contraindications to metformin therapy in patients with Type 2 diabetes--a population-based study of adherence to prescribing guidelines. Diabet Med (2001) 1.71
The role of adiposity in cardiometabolic traits: a Mendelian randomization analysis. PLoS Med (2013) 1.70
Risk of cardiovascular disease and total mortality in adults with type 1 diabetes: Scottish registry linkage study. PLoS Med (2012) 1.69
Cohort Profile: Generation Scotland: Scottish Family Health Study (GS:SFHS). The study, its participants and their potential for genetic research on health and illness. Int J Epidemiol (2012) 1.67
Diabetes and driving. Diabetes Care (2012) 1.66
Adiposity-related heterogeneity in patterns of type 2 diabetes susceptibility observed in genome-wide association data. Diabetes (2008) 1.64
Genetic evidence that raised sex hormone binding globulin (SHBG) levels reduce the risk of type 2 diabetes. Hum Mol Genet (2009) 1.61
Underlying genetic models of inheritance in established type 2 diabetes associations. Am J Epidemiol (2009) 1.60
Effects of acute insulin-induced hypoglycemia on indices of inflammation: putative mechanism for aggravating vascular disease in diabetes. Diabetes Care (2010) 1.57
Using the SenseCam to improve classifications of sedentary behavior in free-living settings. Am J Prev Med (2013) 1.56
Hypoglycaemia and cognitive function. Diabetes Obes Metab (2005) 1.53
Effect of Metformin on mortality in patients with heart failure and type 2 diabetes mellitus. Am J Cardiol (2010) 1.50
No differences in mortality between users of pancreatic-specific and non-pancreatic-specific sulphonylureas: a cohort analysis. Diabetes Obes Metab (2007) 1.50
Transmission of carbapenem-resistant pathogens in New York City hospitals: progress and frustration. J Antimicrob Chemother (2012) 1.49
Prevalence of and risk factors for hepatic steatosis and nonalcoholic Fatty liver disease in people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study. Diabetes Care (2011) 1.46
Insulin analogues and other developments in insulin therapy for diabetes. Expert Opin Pharmacother (2003) 1.45
Costs of managing severe hypoglycaemia in three European countries. J Med Econ (2009) 1.40
Short-term, delayed, and working memory are impaired during hypoglycemia in individuals with type 1 diabetes. Diabetes Care (2003) 1.36
Serum thyroid-stimulating hormone concentration and morbidity from cardiovascular disease and fractures in patients on long-term thyroxine therapy. J Clin Endocrinol Metab (2009) 1.36
Clinical and ultrasonographic features of abdominal tuberculosis in HIV positive adults in Zambia. BMC Infect Dis (2009) 1.35
Reduced-function SLC22A1 polymorphisms encoding organic cation transporter 1 and glycemic response to metformin: a GoDARTS study. Diabetes (2009) 1.34
Development and validation of a model for predicting emergency admissions over the next year (PEONY): a UK historical cohort study. Arch Intern Med (2008) 1.34
Association between raised inflammatory markers and cognitive decline in elderly people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study. Diabetes (2009) 1.34
Diabetic retinopathy and cognitive decline in older people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study. Diabetes (2010) 1.32
The Edinburgh Type 2 Diabetes Study: study protocol. BMC Endocr Disord (2008) 1.30
Locality deprivation and Type 2 diabetes incidence: a local test of relative inequalities. Soc Sci Med (2007) 1.30
Mendelian randomization studies do not support a role for raised circulating triglyceride levels influencing type 2 diabetes, glucose levels, or insulin resistance. Diabetes (2011) 1.29
Cardiovascular risk in type 2 diabetes is associated with variation at the PPARG locus: a Go-DARTS study. Arterioscler Thromb Vasc Biol (2004) 1.26
Effect of socioeconomic status on mortality among people with type 2 diabetes: a study from the Scottish Diabetes Research Network Epidemiology Group. Diabetes Care (2011) 1.26
Mendelian randomization studies do not support a causal role for reduced circulating adiponectin levels in insulin resistance and type 2 diabetes. Diabetes (2013) 1.25
Birth choices in Timor-Leste: a framework for understanding the use of maternal health services in low resource settings. Soc Sci Med (2010) 1.24
Metformin in cancer treatment and prevention. Annu Rev Med (2014) 1.23
Severity assessment of skin and soft tissue infections: cohort study of management and outcomes for hospitalized patients. J Antimicrob Chemother (2010) 1.23
Candidate gene association study for diabetic retinopathy in persons with type 2 diabetes: the Candidate gene Association Resource (CARe). Invest Ophthalmol Vis Sci (2011) 1.22
A worldwide analysis of beta-defensin copy number variation suggests recent selection of a high-expressing DEFB103 gene copy in East Asia. Hum Mutat (2011) 1.21
Interventions for impetigo. Cochrane Database Syst Rev (2012) 1.19
A paucimorphic variant in the HMG-CoA reductase gene is associated with lipid-lowering response to statin treatment in diabetes: a GoDARTS study. Pharmacogenet Genomics (2008) 1.19
Apolipoprotein E genotypes are associated with lipid-lowering responses to statin treatment in diabetes: a Go-DARTS study. Pharmacogenet Genomics (2008) 1.18
Use of gene expression profiling to identify a novel glucocorticoid sensitivity determining gene, BMPRII. FASEB J (2006) 1.15
Adherence to preventive exercises and self-reported swallowing outcomes in post-radiation head and neck cancer patients. Head Neck (2013) 1.15
Reduced incidence of lower-extremity amputations in people with diabetes in Scotland: a nationwide study. Diabetes Care (2012) 1.14
Increased cardiovascular morbidity and mortality in type 2 diabetes is associated with the glutathione S transferase theta-null genotype: a Go-DARTS study. Circulation (2005) 1.13
Pre-eclampsia and the later development of type 2 diabetes in mothers and their children: an intergenerational study from the Walker cohort. Diabetologia (2006) 1.12